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1. Introduction 
Toxoplasmosis is highly prevalent in Brazil, where its prevalence ranks among the highest 
in the world. However, the prevalence of ocular toxoplasmosis may vary from one region to 
another within the country, even in the face of seroprevalence of the same magnitude. For 
over a decade we have been studying toxoplasmosis in Campos dos Goytacazes, which has 
amongst the highest prevalence of the condition already reported. Local social and 
environmental peculiarities influence the risk factors and impact the seroprevalence when 
analyses are performed in local populations stratified by socioeconomic status [1]. Campos 
dos Goytacazes, usually referred to as Campos, is located in the northern state of Rio de 
Janeiro in the most important oil-producing region of Brazil. The city is composed of an area 
equivalent to 4,027 km2, and with 463.731 inhabitants, it is the third most economically 
important city in the state of Rio de Janeiro. Some aspects related to the natural history of 
toxoplasmosis in Campos are connected to its historic past with respect to economic 
agricultural and rural activities that were linked to the Sugar Cane economy.  Sugar 
production prevailed as the most important economic activity until the mid-80s, at which 
point it began gradually giving way to activities related to oil. The city still preserves its 
spatial organization and cultural points, which are characteristics of a city with strong rural 
features.  
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In areas with a high prevalence of infectious and parasitic diseases, such as toxoplasmosis in 
Campos, several challenges are posed to the health authorities with regard to diagnoses, 
accurate assessment of incidence and prevalence, and clinical management of disease 
symptoms. Our studies in toxoplasmosis have focused on the natural history, epidemiology, 
immune response and immunogenetics of infected individuals in order to better understand 
the clinical presentation of the disease. In this chapter, we present in four sections, data 
related to 1) the diversity of presumable toxoplasmic retinal/retinochoroidal scar lesion 
presentations in comparison to other population-based studies of the same nature in Brazil; 
2) the profile of the in vitro immune response of patients in the context of the clinical 
presentation of ocular toxoplasmosis; 3) evidence for candidate genes that are associated 
with susceptibility for or protection against the development of toxoplasmic retinal lesions; 
and 4) the association of ocular toxoplasmosis with other infectious diseases.  
2. The diversity of retinal/retinochoroidal scar lesions in T. gondii 
hyperendemic areas of Brazil  
In the past, most T. gondii retinochoroiditis was thought to be of congenital infection origin. 
However, it is currently accepted that ocular disease is most likely the most common 
potentially severe symptomatic manifestation in acute, postnatally acquired toxoplasmosis 
[2, 3]. The epidemiologic studies in Brazil have contributed to changing that traditional 
belief. In the country, toxoplasmosis is the most frequent cause of infectious uveitis, as in 
many other nations [4-9,56,57]. The prevalence of ocular toxoplasmosis in areas highly 
endemic for T. gondii in Brazil has an important public health impact and differs among 
areas of similar seroprevalence. Population-based studies involving people of ages ranging 
from 10 years to older than 50 years from different regions of the country have shown that 
the prevalence of retinochoroiditis varies from 2.6% to 17.7% [4-8].  
The population-based studies that are used to estimate ocular disease caused by T. gondii 
infection depend on the observation of retinal/retinochoroidal lesion scars via fundoscopic 
examinations, and as in epidemiologic surveys, it is not common to find patients with active 
toxoplasmic lesions. The observed difference in ocular prevalence, even in face of similar 
seroprevalence has oriented studies to better understand and identify the risk factors for 
infection and for the development of toxoplasmic ocular disease.  
Holland and associates in 1996 [3] report the three types of retinochoroidal lesions in 
otherwise healthy patients, described in 1969 by Friedmann and Knox, which are based on 
the localization in the retina, size, vitreous inflammatory reaction and probable prognosis in 
terms of complications or decreased vision. However, for epidemiologic surveys, the lack of 
a classification system or a consensual proposal to describe scar lesions presumably caused 
by T. gondii infections certainly impacts the final prevalence that is determined in various 
studies and, perhaps more importantly, fails to describe asymptomatic, less severe scar 
lesions confined to the retinal pigment epithelium (RPE) that are not commonly seen by 
ophthalmologists in clinical settings. Such lesions might be important not only from an 
epidemiological point of view itself, but, if well studied, they could perhaps aid in the 
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development of new therapeutic approaches that may benefit patients who have more 
severe forms of disease, especially recurrent forms of ocular toxoplasmosis. 
In light of these considerations, subjective criteria certainly influence the clinical diagnosis of 
ocular toxoplasmosis in population-based studies, which are based on the appearance of 
inactive retinal/retinochoroidal scar lesions left by presumed toxoplasmic lesions that were 
previously active. In addition, the ophthalmologists’ clinical experience on the resolution of 
active lesions is important for the recognition of retinal/retinochoroidal toxoplasmic scar 
lesions.  
An important epidemiological study conducted in Brazil by Glasner and associates in 1992 
reported a ranking of probability for the classification of retinal scar lesions that are 
presumably caused by T. gondii infection [4]. The system was established by the authors to 
try to estimate the actual prevalence of ocular toxoplasmosis in a highly endemic area for T. 
gondii infection located in a small village in southern Brazil called Erechim. According to the 
authors, on the basis of a conservative assessment of ophthalmic findings, 17.7% of the 
patients (184 out of 1042 examined) were considered to have ocular toxoplasmosis. They 
categorized the different types of lesions that were identified during the examination of 1042 
individuals and organized them into five groups numbered 1 through 5 according to the 
probability that the lesion was caused by T. gondii infection. Those classified from grade one 
to grade three were considered to be definitively caused by T. gondii infection [4].  We found 
the authors’ initiative very important, and with the same objective, we have proposed some 
descriptive criteria to classify the most commonly found retinal/retinochoroidal lesions from 
our population-based work in Campos dos Goytacazes [7, 10, 11]. However, as mentioned 
earlier, the nature of the toxoplasmic retinal/retinochoroidal scar lesions, or even active 
lesions described during the fundoscopic examination, is subjective. Thus, the decision as to 
whether a scar lesion was caused by T. gondii infection depends, to some extent, on 
subjective criteria. To minimize the intrinsic characteristic of this decisional process, in 
population-based studies, a group of ophthalmologists consensually decide which scar 
lesions have the greatest probability of being caused by toxoplasmic infection. During this 
process, the ophthalmologists are usually uninformed as to whether the patient serology is 
positive or negative for T. gondii.  
There is a type of retinal/retinochoroidal scar lesion that is universally accepted as being 
healed from active retinal/retinochoroidal inflammation caused by T. gondii infection. These 
scars usually result from the active typically visible yellow-white focus with fluffy borders, 
which may or may not be accompanied by vitreous inflammation that limits the 
visualization of the posterior pole [12]. However, there exist other lesions that are equally 
recognized by specialists as toxoplasmic lesions, termed as “atypical” toxoplasmic lesions, 
and their active forms have been reviewed [3, 12]. The frequency of scar lesions healed from 
“atypical” active toxoplasmic lesions in population-based studies is not well known because 
in previous studies, with the intent of avoiding an over estimation of ocular toxoplasmosis, 
only scars healed from typical lesions, which are most likely equally typical in terms of 
toxoplasmic retinochoroidal scar lesion representativeness, have been usually used to infer 
the ocular prevalence of T. gondii infection in epidemiologic surveys. As a consequence, 
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identifying the actual prevalence of ocular toxoplasmosis in areas highly endemic for T. 
gondii in Brazil constitutes a challenge in practice and may be underestimated. In fact, the 
existence of retinal/retinochoroidal scars most likely healed from non-typical toxoplasmic 
retinal/retinochoroidal lesions have been reported in endemic areas [4, 7, 9-11, 13] as 
discussed later in this section.  
Two groups working independently in Rio de Janeiro state, one from the State University of 
North Fluminense (UENF) at  Campos dos Goytacazes and another from the Oswaldo Cruz 
Foundation, have conducted epidemiological and human immunogenetic studies that can be 
directly compared because the same criteria for ocular scar lesions classification was adopted 
for both [9, 11]. The criteria for characterizing scar lesions that were presumably caused by T. 
gondii infection adopted by both groups were based on the morphological aspects of the scars, 
primarily the pigmentation and the degree of retinal tissue damage. The lesions were termed 
as type A, type B or type C by the Campos dos Goytacazes group [7, 11] and as type 1, type 2 
or type 3, respectively, by the Oswaldo Cruz Foundation group [9]. The Oswaldo Cruz group 
investigated the retinochoroiditis caused by T. gondii infection in a rural area (Santa Rita) of 
Barra Mansa, located at southern part of the Rio de Janeiro state [9]. Campos dos Goytacazes 
and Santa Rita are both supplied by the Paraíba do Sul River, which supplies water to 
approximately 4.8 million persons in Brazil. The cities are located approximately 390 km from 
each other; Campos at north of the state and Barra Mansa in the south.  
In 2005, the Campos group published a proposal (in Portuguese) to categorize/classify the 
diverse foci of retinochoroiditis scars found in a survey conducted from 1997-1999 on the 
prevalence and risk factors for T. gondii infection. In the proposal, the group termed the 
toxoplasmic scar lesion foci as type I, type II or type III [10]. In a previous publication of 
2001 [7], the Campos group had termed such lesions as type A, type B and type C, 
respectively. However, because of the possibility of confusion and some relation with the 
three archetypal T. gondii lineages, which are termed type I, II or III based on the genomic 
sequence associated with their virulence in mice [14, 15], we returned to the original 
classification nomenclature of type A, type B and type C [7, 11]. The following descriptions 
in quotes are related to the three classes of retinal/retinochoroidal foci scars found in T. 
gondii seropositive individuals in endemic areas to toxoplasmosis published by both the 
Campos and Oswaldo Cruz Foundation groups: “class A lesions present well-marked 
boundaries, usually surrounded by a pigmented halo and extensive destruction of the retina 
and choroid. Class B lesions are characterized by a surrounding hypopigmented halo and a 
smaller degree of tissue destruction in comparison to class A. Class C lesions are basically 
areas of retinal pigment epithelium hyperplasia or atrophy with a smaller degree of tissue 
destruction compared to class A and B” [11] and “type 1 lesions boundaries are well marked 
with a halo of hyperpigmentation and central area of retinochoroidal atrophy, type 2 lesions 
with hypopigmented halo and central hyperpigmented area and type 3 lesions 
hyperpigmented or hypopigmented consistent with hyperplasia or atrophy of the retinal 
pigment epithelium” 1 [9]. 
                                                                 
1 Translated from the original publication in Portuguese (ref.9) 
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Figure 1 shows representative type A, B and C scar lesions that appear isolated in one or 
both eyes as well as multiple lesions of different types (AB, ABC, AC and BC) in one or both 
eyes. Type A and B scar lesions have a higher probability of being recognized by 
ophthalmologists as being caused by T. gondii infection. Certainly, out of the context of 
epidemiological surveys to estimate ocular toxoplasmosis, type C scar lesions would, with 
very low probability, be considered as retinal scars healed from ocular toxoplasmosis. Some 
aspects intrinsic to this type of scar lesion led us to believe they are caused by T. gondii 
infection; these are i) their high frequency in patients who are seropositive for T. gondii; ii) 
their common association with the more typical type A and B scar lesions; and iii) their 
differentiated profile of the specific in vitro cellular immune response of patients presenting 
this type of lesion compared to T. gondii seropositive patients who present no ocular lesions. 
We have evidence that the profile of their specific in vitro cellular immune response is most 
likely a result of a very efficient mild to minimal inflammatory intraocular reaction against 
T. gondii that causes only superficial injury to RPE, which can result in pigmented or 
apigmented scars, as we shall see later in this chapter. 
 
Figure 1. Fundus photograph of representative retinal/retinochoroidal non-active scar lesions. Panel A 
and panel B represent single type A and B scar lesions, respectively. Panels C and D represent single 
type C scar lesions that are hyper- and hypopigmented, respectively. The scar lesions by type are 
indicated by colored arrows: red represents type A scar lesions, orange represents type B scar lesions 
and yellow indicates type C scar lesions. The two pictures at the bottom (panels E and F) show multiple 
scar lesions of type ABC (with arrows red, orange and yellow) and a multiple scar lesion of type AB 
(with arrows red and orange). 
In a survey conducted in 1997-1999 to investigate the seroprevalence of toxoplasmosis in 
Campos [1], during which 1436 persons were investigated and the local waterborne nature 
of T. gondii infection was shown, the study population was divided into three socio-
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economic strata. In addition to other factors, the geographic localization of the selected 
people was important for differential T. gondii seroprevalence levels. Then, for the groups 
living in slums and rural areas from Campos who shared the same lower socio-economic 
strata termed as population 1 (P1), the T. gondii age adjusted serumprevalence was 84% [1]. 
For the middle and upper socioeconomic groups, termed as population 2 (P2) and 
population 3 (P3), 62% and 23% of T. gondii age adjusted seroprevalence was identified, 
respectively. However, the lower age adjusted seroprevalence of toxoplasmosis observed for 
P3 (23%) and P2 (62%) in comparison with P1 (84%) [1] contrasted with the similar overall 
ocular prevalence found for the three populations namely, P3 (12%), P2 (10%) and P1 (12%) 
[7]. It is important to mention that for the estimation of ocular disease prevalence caused by 
T. gondii infection in Campos, which was published in 2001, a more conservative basis for 
diagnose was adopted. The diagnosis considered only the typical appearance of 
retinochoroidal scar lesions for the prevalence calculation [7]. For the Santa Rita study, 
which will be compared to the Campos study, only the population living in rural areas was 
evaluated, and the T. gondii seroprevalence was found to be 65.9%; however, no risk factor 
was reported [7]. For the Campos study, we observed that despite the same seroprevalence 
among those living in rural areas and those living in slums (both from P1 strata), the 
prevalence of ocular disease was different. Namely, when the lower socio-economic strata 
were sub-stratified according to people living in rural areas and those living in slums, we 
found that the prevalence of ocular disease was 14% for those living in rural areas and 8% 
for those living in slums [7]. For the Santa Rita study, which involved only the rural 
community, ocular disease prevalence was reported as 5.8%. 
For the past six years, we have conducted randomized samplings of individuals older than 
10 years belonging to P1 and P2 (lower and middle socio-economic strata, respectively, from 
the total Campos population). We have collected peripheral venal blood for T. gondii 
serologic evaluation and patients have been examined  by indirect  ophthalmoscopy . Some 
patients who may have participated from the previous survey [1] were re-evaluated 
clinically and serologically by collecting new blood samples for the immunological and 
immunogenetic studies. The results of the serologic prevalence and the prevalence of ocular 
disease from 411 patients that were examined over the past six years are reported in Table 1 
to compare our results with the Santa Rita study population.  
The frequencies of types of scar lesions, considering the total number of patients who 
presented scar lesions in each study, are shown in the Table 1. There were 41 persons with 
scar lesions out of 706 T. gondii seropositive individuals from Santa Rita and 94 subjects with 
scar lesions out 314 T. gondii seropositive individuals from Campos.  We observed that the 
frequency of type A (type 1) lesions was much higher in Santa Rita (41.5%) than in Campos 
(19.1,%) and that the most frequent type of scar lesion per patient from Campos was type C 
(28.7%); in Santa Rita, the frequency of the type C (Type 3) scar lesion was 12.2%. Curiously, 
the frequency of type B (type 2) lesions was very similar in both areas: 24.4% in Santa Rita 
and 24.5% in Campos. The sum of multiple lesions types in both areas was also similar. 
Namely, the sum of the frequency of individuals who presented AB + ABC + AC + BC as 
well as 1 and 2 + 1 and 2 and 3 + 1 and 3 + 2 and 3 scar lesions was 27.7% and 22% for 
Campos and Santa Rita, respectively.  
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 Santa Rita (Barra Mansa)  Campos dos Goytacazes 
 n %  n % 
Study population 1071  
 
 411  
T. gondii seropositivity 706 65.9  314 76.6 
Type of scar lesions n % Type of scar lesions n % 
1 17 41.5 A 18 19.1 
2 10 24.4 B 23 24.5 
3 5 12.2 C 27 28.7 
1 and 2 2 4.9 AB 9 9.6 
1 and 3 4 9.8 AC 2 2.1 
2 and3 2 4.9 BC 7 7.4 












* The total prevalence of ocular disease in Campos can be expressed in three levels. 
1- Considering only the persons who present type A scar lesions, which are those universally recognized as being 
healed from the typical toxoplasmic retinochoroidal active lesions. This value is calculated as the sum of single type A 
scar lesions (n=18) plus the multiple type lesions that contain the type A scar lesion,(AB n=9) + (AC n=2) + (ABC n=8), 
totaling 37 individuals. This gives the prevalence of ocular disease of 11.7%. 
2- Considering the individuals who present type A single and multiple type scar lesions plus the individuals 
presenting type B single (n=23) plus multiple type lesions (BC n=7), which adds up to a total of 67 individuals and 
gives a prevalence of 21.33%. 
3- Considering all the people who present type A and type B single and multiple type lesions and persons who present 
with type C scar lesions, which totals 94 individuals and gives a prevalence of 29.9%. 
Table 1. Comparison Between the T. gondii Seroprevalence and Retinal/Retinochoroidal Scar Lesions 
Prevalence from Campos dos Goytacazes (RJ) and Santa Rita (Barra Mansa-RJ) 
Considering that out of 411 clinically and serologically examined patients 314 were 
seropositive for T. gondii, the seroprevalence was estimated at 76.6%. This prevalence 
represents the intermediate value between the prevalence observed for P1 (84%) and P2 
(62%) reported in 2003 [1] and calculated by P1(84%) + P2(62%)/2 = 73%. The same was 
observed for the expected and found toxoplasmic ocular prevalence; i.e., adopting the same 
highly conservative criteria of 2001 to compute toxoplasmic scar lesions and considering 
only the individuals who presented typical lesions (type A scar single or multiple lesions, 
i.e., the sum of type A scar lesions plus scar lesions of type AB, ABC and AC), we found a 
toxoplasmic ocular prevalence of 11.7% (37 out of 314 individuals). Once again, the 
prevalence corresponded to that would be expected from that observed in 2001: 10% for P1 
and 12% for P2 [7], as P1(10 %) + P2(12%)/2 = 11%. However, if we consider type B and type 
BC scar lesions together with type A and type AB, ABC, and AC scar lesions to calculate the 
toxoplasmic ocular prevalence in Campos, we find 21.33% (67 out of 314). Furthermore, if 
we additionally consider type C scar lesions to calculate the frequency, the prevalence of 
toxoplasmic ocular lesions in Campos increases to 29.9% (94 out of 314). It is important to 
keep in mind that the prevalence values are related to the population extract P1 plus P2 
older than 10 years and that it is after the age of 10 that we observe a substantial increase in 
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T. gondii seroprevalence for P1 and P2, based on previous studies in Campos [1]. 
Furthermore, it is only after 10 years of age that we observe the elevation of ocular 
toxoplasmosis prevalence in population-based studies in general [2].  
In the context of the diversity of retinal/retinochoroidal scar lesions found in epidemiologic 
surveys in Brazil, another important report from the Erechim area was conducted by 
Silveira and associates in 1999 [13], seven years after the study conducted by Glasner and 
associates in 1992 [4]. A group of patients that were previously examined in 1992 presented 
a type of hyperpigmented scar lesion presumably caused by T. gondii infection and termed 
as “atypical” in comparison with those were termed as “typical” lesions. Some of those 
patients had “atypical” scar lesions that evolved to “typical” toxoplasmic retinal lesions in 
the time frame of 7 years. The description of the hyperpigmented “atypical” lesions from 
patients of Erechim fulfills all but one of the criteria we have used to classify type B 
toxoplasmic scar lesions in Campos [13]. The difference between Silveira’s description and 
our description is that we do not consider size to define the type of scar in any of our 
classification criteria. Instead, we consider the type of pigment distribution in the scar and 
the degree of the retinal tissue damage, namely the degree of tissue damage that can be 
inferred by indirect opththalmoscopy, considering the natural limitations for this type of 
examination in terms of tissue evaluation damage. In the referred study from Erechim, 
Silveira and associates showed that at 7-year follow-up, 3 persons of 13 subjects presented 
“atypical” scar lesions that evolved to “typical” toxoplasmic retinochoroidal scars. They 
concluded that the typical new lesions arose from or adjacent to the pre-existing atypical 
lesions in two of the three patients based on photographs and drawing of atypical scar 
lesion location seven years prior [13]. 
As stated earlier, the criteria used to classify scar lesions as type A, B or C are morphological 
based on the pigment appearance and the degree of retinal damage. However, we believe 
that information regarding their size and localization could be useful for future comparative 
studies in other endemic areas of Brazil and abroad. We present the frequency of 
localization and sizes of 85 scar lesions from 49 patients, some of which were involved in 
immunological and immunogenetic studies conducted in Campos [16-18]. In Figure 2, a 
fundoscopy picture from a normal (presenting no retinal damage) individual is shown. The 
numbers indicate four retinal region (code/index) that are used to compute the scar lesion 
localization for frequency calculation purposes, as shown in Table 2. Each retinal region 
shown in Figure 2 is assigned an arbitrary number (index/code) as follows: equatorial (1), 
macula (2), posterior pole / macula (3), posterior pole (4); the periphery (5) shown in Table 2 
does not appear in Figure 2 because it is not usually visible in fundoscopic pictures. Each 
scar lesion was computed  independently if an individual exhibited more than one type of 
scar lesion in one or both eyes, such as A, B or C or a combination of types, such as AB, AC, 
ABC, or BC, irrespective of their locations. Thus, from the 49 individuals who presented scar 
lesions, a total of 15 type A scar lesions, 34 type B scar lesions and 36 type C scar lesions 
were considered for analysis, totaling 85 scar lesions.The median value  of scar from the 
most severe lesions (type A) that was 2, presentes a numeric value (index/code)  arbitrarily 
attributed to denote location on the retina, that was lower compared to values observed for 
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the locations of type B (median value= 4) and C (median value =5) scar lesions. This fact 
illustrates that the median locations of type A scar lesions (median value =2) are preferably 
in regions closer to the macula (see Figure 2), whereas type C lesions  are preferentially 
located in peripheral regions of retina. The statistical comparison among the different types 
of toxoplasmic scar lesion locations was tested using a Kruskal-Wallis test followed by a 
Dunns test. A significant difference (p ≤0.01) was found between the localization of type A 
scars and type C scars. No significant difference between the locations of type A and B scar 
lesions was found. Between type B and type C scar lesions, a significant difference (p< 0.01) 
was also found.  
 
Figure 2. Fundoscopic photograph of a normal retina indicating the regions: equatorial (1) macular (2), 
posterior pole/macula (3) and posterior pole (4). Region 5, which corresponds to the periphery, is not 
shown (see text and Table 2). 
 
Lesion localization region 
Location Code (Index) of 
lesion in retina 
Frequency of occurrence (n) 
of each scar type lesion 
Equatorial 1 A(6) B (15) C (9) 
Macular 2 A(5) B (1) C (0) 
Posterior pole/Macula 3 A(1) B (0) C (0) 
Posterior pole 4 A(1) B (5) C (2) 
Periphery 5 A(2) B (13) C (25) 
Table 2. Frequency of the Topographic Location of Retinal/Retinochoroidal Scar Lesions of type A, type 
B and type C in the retina 
The sizes of the same 85 scar lesions were also measured in terms of optic disc size (disc 
diameter, dd) at the slit lamp with a 78 D lens in a normal clinical ophthalmoscopic 
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examination.. Table 3 shows the scar lesion types sizes that were categorized in 4 size 
ranges: 0 to 0.5 dd, 0.6 to 1 dd, 1.1 to 1.5 dd, and 1.6 to 2.0 dd. The four size ranges 
corresponded to a code/index number from 1 to 4, respectively, for the statistical analysis 
objective. The diameter of the optical disc of each subject was used as a parameter for 
determining the size of the scar lesions of the same person. There is no proportional 
relationship defined between the disc diameter and the arbitrary attributed code/index 
number. The frequency of occurrence by size of each of the 15 type A scar lesions, 34 type B 
and 36 type C scar lesions is shown in Table 3, where the three scar type sizes were 
compared in terms of the relationship between the type and the size range measured for the 
disc diameter (dd), as explained above. The type A scar lesions (healed from the most severe 
lesions) exhibited sizes significantly larger (median value = 2.2) p ≤ 0.001 than the type C 
scar lesions (median value = 1.0) but not significantly larger than type B scar lesions (median 
value =1.8), which are of middle severity in terms of retinal damage. A significant difference 
(p ≤ 0.001) relative to the size of the type B ocular scar lesions was also observed in 
comparison with type C scar lesions, which were on average smaller than type B lesions. It 
is important to mention that the age of the patient can influence the size of the optical nerve 
(diameter) [19], which can interfere with these types of measurements. However, the 
average age between groups did not differ statistically, and therefore this factor likely did 
not affect our evaluation. Nonetheless, the size measurement was not considered in our 
proposed criteria to classify scar type lesions, and it is discussed here solely to provide a 
better representation of the diversity of the scar lesions we have found with a reference for 
the measurement, which can be useful for comparative studies in other areas from Brazil 
and abroad.  
 
Size of lesion 
in diameter disk (dd)  
Size code (index)  
of retinal lesion 
Frequency of occurrence (n) 
of each lesion type 
0 – 0.5 1 A(3) B (17) C (35) 
0.6 – 1 2 A(7) B (9) C (1) 
1.1 – 1.5 3 A(2) B (6) C (0) 
1.6 – 2.0 4 A(3) B (2) C (0) 
Table 3. Frequency of the Size of Retinal/Retinochoroidal Scar Lesions of type A, type B and type C in 
the Retina 
The average age between groups did not differ statistically. The average age of patients 
presenting scar lesions of type A was 44 yrs and AC 52 yrs which are higher in comparison 
with the other types of lesions (type B, BC and ABC 29 yrs, type AB 32 yrs and type C 36 
yrs) and consistent with previous findings that have shown that age is an important factor 
for the severity of ocular toxoplasmosis [20]. Nevertheless, if we assume that the “atypical” 
hypermigmented scar lesions that were described to occur in T. gondii seropositive patients 
from Erechim [13] are the same type of type B scar lesion we describe for patients from 
Immunological and Immunogenetic Parameters on the Diversity of Ocular Toxoplasmosis: Evidence  
to Support Morphological Criteria to Classify Retinal/Retinochoroidal Scar Lesions in Epidemiologic Surveys. 155 
Campos, the data are similar regarding the age of the patients presenting those lesions, 
which were more common among younger patients (under 17 years of age) compared to older 
individuals [13]. This fact might indicate that type B scar lesions would be related to more 
recent infections. Unfortunately, age as a function of the type of scar lesion was not reported in 
the Santa Rita study [9]. We can conclude from the set of data presented and reported from 
other studies that the lack of a set of consensual criteria for scar lesions presumably caused by 
T. gondii infection may account, at least partially, for the differences in the reports of 
categorization/classification of toxoplasmic ocular prevalence observed in Brazil. 
3. Immunological parameters in the context of the diversity of 
retinal/retinochoroidal scar lesions from T. gondii seropositive patients  
T. gondii infection in both mice and humans is characterized by a host response with high 
levels of pro-inflammatory cytokines, such as interleukin 12 (IL-12), tumor necrosis factor 
(TNF)-α and interferon gamma (IFN- γ), all of which have been implicated in both the 
regulation of parasitic replication in the host as well as in the ocular pathology [11, 16, 21-
24]. The importance of the immune response of patients infected with T. gondii against the 
parasite has been recognized, together with other variables comprising the multifactorial 
nature of ocular toxoplasmosis. In this section, we present results from the in vitro 
parameters of the cellular immune response of T. gondii seropositive patients with and 
without ocular retinal/retinochoroidal scars and control groups of seronegative patients 
exposed to the same risk of infection, which involved the consumption of untreated water 
from wells or other natural water sources [1], against soluble antigens from T. gondii 
tachyzoite forms (STAg). Cytokines, chemokines, and isotypes of immunoglobulins have 
been evaluated in an effort to identify potential predictive factors for the development or 
prevention of ocular disease. All of the immunological parameters have been analyzed 
considering different groups of patients arranged according to the similarity in the 
retinal/retinochoroidal scar lesion group.  
A pro-inflammatory specific T helper 1 (Th-1) oriented response is observed mainly in 
groups of patients presenting retinochoroidal scar healed from severe lesions, which 
suggests that the exacerbation of the immune response can be related to tissue damage, and 
its attenuation/regulation may be related to the development of minor retinal damages. The 
central role of IFN- seems to be important in both cases, namely, in exacerbated and in the 
regulated context of in vitro cellular immune response, suggesting that the cellular immune 
responses against T. gondii in the eye should be suitably tailored  [11, 16, 21-23], as we shall 
see later. Other molecules and cells related to the regulation of secretion of IFN-γ include IL-
13, chemokines, isotypes of immunoglobulins, NK cells and T CD8 lymphocytes in relation 
to the development or prevention of development of toxoplasmic ocular pathology have 
also been investigated [11, 16, 21, 22]. The immunological parameters studied have also 
made way for the election of candidate genes to be investigated in studies of genetic 
association with ocular toxoplasmosis, as we shall see in the next section.  
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However, we have evaluated many immunological parameters we have chosen three to 
better illustrate the profile of the cellular immune response as a function of the type of scar 
lesion presented by patients. The first is IFN-, the prototype of Th-1 response that has been 
shown to be of vital importance for inducing anti-T. gondii effectors mechanisms to control 
the parasite replication in the host [25]. The second, IL-13, is a Th-2 cytokine whose 
functions overlap considerably with those of IL-4, and it is important for the control of the 
Th-1 response but that has not been well studied in toxoplasmosis. The third chemokine, 
CXCL 10 (interferon gamma-induced protein 10- IP-10), is secreted in response to IFN- 
stimulation. Recently, it was demonstrated in a murine model that treatment of chronically 
infected mice with anti-CXCL10 antibodies led to decreases in the numbers of CD3+, CD4+, 
and CD8+ T cells and the amount of IFN- mRNA expression in the retina and an increase in 
replicating parasites and ocular pathology, which provides evidence that the maintenance of 
the T-cell response and the control of T. gondii in the eye during chronic infection is 
dependent on CXCL10 [26]. Cytokines and chemokine measurements were carried out using 
supernatants collected from PBMC cultures stimulated with T. gondii antigens. The 
concentrations were determined by using the BD Cytometric Bead Array (CBA) human 
chemokine kit and Th1/Th2 cytokine kits and Human IL-13 Flex Set, according to the 
manufacturer's protocol (BD Pharmingen). 
Table 4 summarizes the individuals for which the specific immune response against T. 
gondii has been evaluated. The T. gondii serology and age range is provided. All the 
seronegative (SN) individuals, seropositive (SP) without ocular scar lesions (NL) and 
individuals with retinal or retinochoroidal scar lesions categorized as type A, type B or type 
C, as explained above, were sex- and age-matched among the groups. We observed that 
there was a similarity in terms of the profile of the in vitro immune response between 
patients who presented multiple scar type lesions and patients who presented single type A 
or B scar lesions, depending on which cytokine had been considered among the groups for 
comparison. Then immunological analysis, presented in Figure 3 and Figure 4, show the 
patients presenting multiple type scar lesions (AB, ABC, AC or BC) grouped in two different 
ways. This optional arrangement of patients, considering the multiple types of scar lesions, 
has helped us to propose three settings of immune responses that match the clinical 
presentation of ocular toxoplasmosis, which has been inferred in our studies by the 
morphological appearance of the retinal/retinochoroidal lesions. The reasoning behind the 
optional arrangements is related to the common presence of type B and type A scar lesions 
in two (AB and ABC) out of the four (AB, ABC, AC and BC) multiple type scar lesions. In 
Figure 3, they were grouped as follows: patients with AB, ABC and AC scar lesions are all 
included in the type A scar lesion group, which we considered the highest categorization in 
terms of tissue damage severity of scar lesion, and the patients presenting scar lesions of 
type BC were included in the group of type B scar lesions. The type C scar lesion group is 
composed of individuals presenting only type C scar lesions. 
Concerning to the cytokine and chemokine production, we observed two levels of 
production that are termed as high or low levels. As a consequence, individuals producing 
low or high levels of cytokines or chemokines are termed high or low cytokine/chemokine 
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producers. To calculate the frequency of high and low levels of production, an arbitrary cutoff 
value was established for each cytokine and chemokine based on the visual dispersion 
graphics, where it was possible to determine a dividing line that separated the secretion levels 
into two scattered clusters, one high and another low. The capability of producing low and 
high levels of IFN- is a phenotypic characteristic that is genetically associated with a single 
nucleotide polymorphism in the first intron of the human IFN- gene, as determined by 
Pravica and colleagues in 2000 [27].  The capability of producing low and high levels of IFN- 
can be observed in other infectious disease [28, 29]. The levels secreted by each patient that fell 
above the cutoff values were considered high values, and the levels that fell below the cutoff 
values were considered low values. The median value of the two cytokines IFN- and IL-13 
and the chemokine CXCL10 secretion was utilized to help to establish the exact numeric cutoff 
values to be used for each cytokine and chemokine: 29.58ng./mL, 194.12 pg/mL, and 113.72 
ng/mL for IFN-, IL-13 and CXCL10, respectively. Those median values refer to patients who 
presented type C scar lesions. This group was chosen because it exhibited the best spreading 
profile, producing two very clearly separated clusters corresponding to levels of high and low 
producers of the two cytokines and the chemokine that were evaluated. 
 
Groups 
Toxoplasmosis serology and 
scar lesion type 
n Mean Age (SE)1 
1 SN2 9 29.6 (5.2) 
2 SP3/NL4 21 28.8 (4.7) 
3 SP/type A5-6 18 35.5 (6.0) 
4 SP/type B5-6 21 27.5 (4.4) 
5 SP/type C5 20 31.7 (5.1) 
1 (SE) = standard error 
2 T. gondii-seronegative individuals (SN)  
3 T. gondii-seropositive individuals (SP) without ocular lesions 4(NL) 
5 T. gondii-seropositive individuals (SP) with  retinochoroidal/retinal scars lesions categorized as class type A, type B or 
type C.  
6 In the group of type A scar lesions, individuals with single type A scar lesions (N=4) and multiple scars lesions type 
AB (N=5), ABC (N=7) and AC (N=2) were also included, totaling the 18 individuals shown in the table. In the group of 
type B scar lesions, individuals with single type B lesions (N=14) and individuals with multiple scars lesions type BC 
(N=7) were included, totaling the 21 individuals shown in the table. 
Table 4. Groups of Individuals Involved in Immunological Studies According to Toxoplasma gondii 
Serology, Age and the Presence or Absence of Retinal/Retinochoroidal Scar Lesions. 
Figure 3 shows the frequency of IFN-, IL-13 and the chemokine CXCL 10 secretion, 
considering only patients who produced high levels of each cytokine, i.e., the high 
producers. The lowest frequency of high IFN- producers (43%) was observed in the group 
of patients with type B scar lesions even compared with patients presenting no lesions (SL) 
(52%), and the highest (61%) was observed in the group that presented type A scar lesions; 
50% of the patients with type C lesions presented high levels of IFN- production. However, 
for IL-13 production, we observed that the lowest frequency of high producers was 
observed among patients with type A (28%) scar lesions, in comparison with patients who 
presented no lesions (SL) (29%). The highest production levels were observed among 
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patients who presented type C scar lesions (50%); 30% of the patients with type B scar 
lesions presented high levels of IL-13 production. Curiously, for the CXCL 10 chemokine, 
which is inducible in response to IFN-, the highest frequency of high producers was 
observed among patients with type C scar lesions (53%), and the lowest frequency of high 
producers was observed among patients with type B scar lesions (21%), which is 
comparable to the frequency of high production observed in patients without ocular lesions 
(SL) (23%); 38% of patients with type A scar lesions were high producers of CXCL10. These 
data suggest that CXCL10 in humans can have the same role regarding T. gondii infection 
that it plays in mice: to control the numbers of CD3+, CD4+, and CD8+ T cells and the 
amount of IFN- mRNA expression in the retina and, in consequence, the replication of 
parasites in the eye during the chronic phase of T. gondii infection [26]. In addition, it is 
evident that patients who present type C scar lesions secrete high levels of IL-13, a cytokine 
that can control the levels of pro-inflammatory cytokines without affecting IFN- secretion 
within the eye, as shown in experimental models. The role of IL-13 was shown to inhibit 
pro-inflammatory cytokines, with the exception of IFN-, within the eye in a model of 
endotoxin-induced uveitis (EIU) in the Lewis rats. Intraocular injection of IL-13 
significantly inhibited the production of pro-inflammatory cytokines and resulted in less 
intense ocular inflammation without down-regulating the levels of local IFN- [30]. In 
addition, the induced auto-immune uveitis with human retinal S-antigen in monkeys was 
treated with human recombinant IL-13 [31]. The injection of IL-13 significantly inhibited 
the inflammation in the eyes where the disease was present when the treatment was 
initiated. The beneficial effect of IL-13 extended into the 4-week follow-up period; 
however, after cessation of therapy, there was a progressive increase of inflammation in 
the IL-13 treated group. Nevertheless, the authors concluded that attention should be paid 
to the promising modality of treatment for severe uveitis with IL-13 [31]. The profile of 
the immune response against T. gondii exhibited by patients who presented type C scar 
lesions is suggestive of a favorable inflammatory environment within the eye for the 
maintenance of a controlled response to prevent both parasite growth and tissue damage, 
which could be caused by the parasite growth itself and/or may be a consequence of an 
exacerbated immune response against the parasite. In this context, it is important to 
highlight the fundamental importance that has been demonstrated for the role of IFN- in 
toxoplasmosis [25]. 
IFN- can induce tryptophan degradation, which is critical to the parasite’s survival [32]. 
The effects of interferon on multiplication of T. gondii in in vitro systems seem to be 
dependent on cell type, and a diversity of molecular mechanisms is evident depending on 
the cell type or system. It has been shown in neuronal tissues and cells that nitric oxide (NO) 
production is an important factor for parasite growth inhibition [33]. However, parasite 
growth inhibition was found to be independent of a nitric oxide-mediated or tryptophan 
starvation mechanism [34]. The control of parasite interconversion between tachyzoites and 
bradyzoites in the eye is also fundamentally dependent on IFN- [35]. Furthermore, in 
primary cultures of human retinal pigment cells (HRPE), T. gondii replication was inhibited 
by the induction of indoleamine 2,3-dioxygenase (IDO), which degrades tryptophan to 
kynurenine. However, nitric oxide production was not detected in this system [36]. 
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Figure 3. Frequency of high IFN-γ IL-13 and CXCL10 (IP-10) producers, which were grouped according to 
the type of scar lesion, as shown in Table 4. The frequency of non-infected seronegative individuals (SN) is 
not shown because in none of them PBMC produced high levels of IFN-gamma, IL-13 and or CXCL10 (IP-
10) under stimulation with soluble T. gondii antigens (STAg). The exact Fisher’s test was used to compare 
the groups in terms of the differences in the frequencies of high cytokines/chemokine producers. 
Significances were found at the levels of * p< 0.05, ** p< 0.01 and *** p< 0.001. Significant differences were 
found between type A and type B scar lesions for IFN-γ production (* p< 0.05), between type C and all the 
other types of scars lesions regarding IL-13 secretion, and between type C and all the other types of scars 
lesions groups for CXCL10 (IP-10). The data regarding PBMC IFN-, IL-13 and CXCL10 from non-infected 
(SN) individuals in response to T. gondii soluble antigens is not shown because none of those patients 
produced high levels of those cytokines or chemokine. 
Based on fundoscopic examinations, type C scar lesions seem to be areas of RPE hyperplasia 
or atrophy. However, they must to be better characterized by new high-resolution cross-
sectional imaging of the retinal tissues (such as using spectral domain optical coherence 
tomography) in order to better clarify their structural changes in the retinal layers. As 
mentioned earlier some aspects showed here led us to accept the relationship between type 
C scar lesions and T. gondii infection one of them is the profile of cellular specific immune 
response of patients who present only type C scar lesions, which is concomitantly abundant 
for IFN-, IL-13 and CXCL10. The reproduction of this type of scar lesion in experimental 
models would be of value to better understand their meaning in ocular toxoplasmosis. 
Because we have been working in a highly endemic area to toxoplasmosis and the majority 
 
Toxoplasmosis – Recent Advances 160 
of the population is T. gondii seropositive, we cannot rule out the possibility of an 
association between the type C scar lesions and other infectious or non-infectious conditions 
whose natures could be genetically predisposed and prevalent in the Campos population.   
As stated previously, patients were grouped in an optional way. Those presenting only type 
A scar lesions comprised a distinct group, taking into account the possibility that in patients 
presenting only type A scar lesions, the course of the immune response could be different 
from that which occurred in patients who presented multiple type scar lesions. There are 
rational and intuitive aspects to this arrangement that are related to various factors, like the 
tendency for the production of higher IFN- levels of in PBMC cultures of patients who 
present only type A scar lesions in response to parasitic antigens and the clinical observation 
that some patients can present type A scar lesions soon after an episode of acute ocular 
toxoplasmosis without a previous history of ocular toxoplasmosis. However, some patients 
present a slower evolution, from mild to severe scar lesions, as described by Silveira and 
associates in a well documented report [13]. As previously stated in this chapter, this 
observation concerns the evolution of hyperpigmented “atypical” toxoplasmic retinal scar 
lesions (similar in appearance to the type B toxoplasmic scar lesions that we have described) 
evolving to “typical” toxoplasmic retinochoroidal lesions (similar in appearance to the type 
A toxoplasmic scar lesions that we have described). Then for the analysis of the immune 
response as a function of the clinical presentation of ocular toxoplasmosis inferred by the 
morphological appearance of the retinal/retinochoroidal scar lesions, the patients were 
optionally arranged into three groups as follows: i) patients presenting only type A scar 
lesions; ii) patients presenting only type B scar lesions plus patients presenting all the 
multiple type scar lesions (AB + ABC + AC + BC); and iii) patients presenting only type C 
scar lesions. Figure 4 summarizes the in vitro parameters of the cellular immune response 
against T. gondii antigens by PBMC of patients in the context of the retinal/retinochoroidal 
lesions considering the three groups of type A, type C and type B plus the multiple type scar 
lesions. Similarly, as shown in Figure 3, considering the profiles of the frequency of high 
IFN-, IL-13 and CXCL10 production by PBMC of patients stimulated with T. gondii soluble  
antigens (STAg), we identified three possible settings of the immune response that can be 
associated with the type of scar lesion. As shown in Figure 4 the Platonic solid octahedron is 
suitable for representing the diversity of scar lesions as a function of the three settings of 
immune responses. On the two edges are the polar scar lesions, type A and type C. In the 
top is the type A scar, which is caused by the most severe type of lesion, and in the bottom is 
the type C scar that likely resulted from a less severe lesions type. Both types of scar lesions 
respectively correlate with the setting of an exacerbated and an adequately regulated Th-1 
response. In the four central vertices are type B scar lesions and the multiple type scar 
lesions AB, AC and BC, and in the center of the octahedron is the multiple type scar lesion 
ABC, all of which correlate with the setting of an immune response characterized by lower 
levels of Th-1 (IFN- and CXCL10) and Th-2 (IL-13) compared with type A and C scar 
lesions. Taking into account this fact, it is possible that other T cells subtypes, such as Th-17, 
for instance, can be important in this setting. Reinforcing this supposition is the fact that we 
have observed recent associations of ocular toxoplasmosis and polymorphisms in the NOD2 
(nucleotide-binding oligomerization domain-containing protein 2) gene and increased IL-
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17A production by PBMC under T. gondii antigenic stimulation in patients with chronic or 
active ocular toxoplasmosis [37]. This fact could explain the lower levels of IL-13, IFN- and 
CXCL10 observed for patients who present type B and multiple type scar lesions. However, 
we have not analyzed patients considering their type of scar lesion groups for the 
mentioned genetic association study due to sample size restrictions, and the genetic 
association found for NOD2 refers to the presence of ocular scar lesions without precisely 
identifying what type of scar lesion it could be.  
 
Figure 4. A Diagram representing retinal/retinochoroidal toxoplasmic scar lesions, as a function of three 
different settings of cellular immune response. The platonic solid octahedron in the center is suitable for 
representing the diversity of scar lesions as a function of the three settings of immune response. On the two 
edges are the type A (at the top) and type C (at the bottom) scar lesions. In the four central vertices of 
octahedron are represented the type B scar lesion and the multiple type scar lesions AB, AC and BC, and in 
the center is a multiple type scar lesion of type ABC. The dotted and solid arrows denote the possible 
evolution of one type of scar lesion toward another type of lesion of greater severity. Not all possibilities of 
evolution are shown in the picture. The frequencies of IFN-,  
IL-13 and CXCL10 (IP-10) high-responders that are shown in the graphics at right define the three settings 
of the immune response shown at left. Each of the three settings correlates with each of the three groups: 
with the scar lesions of the type A at the edge, with the scar lesion of type C at the bottom, or with the type 
B scar lesion plus all the multiple type lesions. The blue arrows shown in the settings denote the levels of 
cytokines and chemokine, as shown in the figure. The scar lesion types are represented by colored circles, 
as explained in the figure. 
The data regarding PBMC IFN-, IL-13 and CXCL10 from non-infected (SN) individuals in 
response to T. gondii soluble antigens is not shown in Figure 3 and Figure 4 because none of 
those patients produced high levels of the cytokines or chemokine in question. In 
conclusion, elements from the cellular immune response, evaluated in PBMC cultures of 
population-based studies evidence that the morphological aspects of retinal/retinochoroidal 
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scar lesions can be associated with three settings of immune response in areas of high 
prevalence of ocular toxoplasmosis. The three settings are i) a Th-1 prominent response with 
high levels of IFN-, moderate to low levels of CXCL10 and low levels of IL-13, which relate 
to single type A scar lesions that are healed from the most severe toxoplasmic ocular lesions; 
ii) a cellular response with moderate to low levels of IFN-  and IL-13 and low levels of 
CXCL10, which relate to multiple type and type B scar lesions; and iii) a sharply regulated 
Th-1 response with moderate to high levels of CXCL 10 and IL-13 and moderate levels of 
IFN-, which relate to type C scar lesions and could protect against tissue damage due to 
parasite replication within the eye.  
4. Ocular toxoplasmosis in association with other infectious diseases: 
Could this impact the clinical presentations of toxoplasmic scar lesions in 
population-based surveys? 
The interaction with other pathogens co-infecting T. gondii seropositive patients will depend 
on their exposure to such eventually co-prevalent parasites in the same area and on the type 
of immune response driven against them. The disease manifestation of T. gondii infected 
patients who become infected with HIV exemplify well this type of interaction and 
modification on the clinical presentation of ocular toxoplasmosis in the face of concomitant 
infections [3]. 
The scar lesions left by healed uveitis caused by T. gondii infections result from the previous 
process of uveal inflammation, which they have in common with other infectious and non-
infectious agents that also cause uveitis, the possibility to compromise the iris, the cilliary 
body, the choroid adjacent structures of the eye including the vitreous, the retina and the 
optic disc.  In this context, the thesis dedicated to this specific issue entitled “Infectious 
uveitis new developments in etiology and pathogenesis” from De Visser [38] underlines the 
necessity in clinical practice to have the support of laboratory data for the confirmation of a 
suspected diagnosis, as similar clinical features may be caused by different pathogens. The 
prompt identification of infectious uveitis entities is of vital importance for treatment 
regimens and visual prognoses of intraocular infections, and differ completely from non-
infectious disorders treatments.  
The thesis also reports on the similarity between retinal/retinochoroidal scar lesions left by 
Rubella eye infection and those left by ocular toxoplasmosis in a well-documented 
retrospective study. The clinical presentations of the focal retinal scars in 11 patients with 
intraocular proof of Rubella virus and in 17 patients with intraocular proof of T. gondii 
infection are compared. Photographic and angiographic records of the 28 patients were 
masked for identification and for infectious agent and were evaluated by four specialists in 
the field of ocular toxoplasmosis. It is reported that no differences were observed between 
the retinochoroidal scar lesions in Rubella virus-positive and T. gondii-positive patients. 
Retinochoroidal scar lesions were considered consistent with the diagnosis of ocular 
toxoplasmosis in 55% of Rubella virus-positive patients and in 88% of T. gondii-positive 
patients by at least three out of the four experts. According to the author of the thesis, two 
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experts considered the retinal lesions in T. gondii-positive patients more frequently 
“consistent with the diagnosis of ocular toxoplasmosis” (P = .010 and P = 0.011). There was a 
substantial agreement between the four experts (Fleiss’ Kappa = 0.623) [38]. 
We cannot rule out the fact that none of the patients have been considered as cases of ocular 
toxoplasmosis in the Campos dos Goytacazes surveys or in surveys from other parts of 
Brazil, as scar lesions left from Rubella virus infection as opposed to T. gondii ocular 
infection were present in their eyes. However, we have to take into account that  Rubella 
was a highly prevalent virus worldwide, including in Brazil, and it is probable that if ocular 
lesions left by Rubella infection were as frequent as in toxoplasmosis, such lesions would 
already have been described as a causative entity of uveitis with epidemiologic importance. 
Rubella virus-caused lesions currently no longer occur due to the vaccination program 
against Rubella virus that was undertaken in many countries, including in Brazil where it 
was introduced 15 years ago.  Hence, despite the clinical relevance of the similarity between 
the Rubella virus- caused lesions and toxoplasma retinal/retinochoroidal scar lesions, we 
believe that from an epidemiologic perspective, this similarity is not relevant. However, 
these data reinforce that the search for parameters, other than the morphological and 
serological, for classifying retinal/retinochoroidal scar lesions presumably caused by T. 
gondii infections should be pursued. Parameters of cellular specific immune response or the 
genotyping of candidate genes with the potential to differentiate between infectious agents 
that produce similar ocular lesions could be of help for disease management.   
We have reported recently in Campos that the host immune response to T. gondii and Ascaris 
lumbricoides evidence co-immune modulation properties that can influence the outcome of 
both infections. One of the most impressive aspect of the immune response of co-infected 
individuals is the prominent specific secretion of IL-13 against Ascaris and T. gondii antigens 
by PBMC of patients who present type C scar lesions in addition to middle to high secretion 
levels of IFN- [11]. This aspect of the immune response seems to be important for the 
control of the parasite retinal replication and most likely for the maintenance of an 
equilibrated T. gondii load and the interconversion of tachyzoites and bradyzoites in the eye 
tissues. T. gondii and A. lumbricoides are both parasites that infect hosts orally; however, they 
elicit polar type I or type II host responses, respectively. Because both parasites are endemic 
in tropical areas, it is likely that co-infections with these organisms have been common 
throughout human evolution. If this is the case, then the host immune response mounted 
against both parasites may have adapted to permit such co-parasitism. The possibility of A. 
lumbricoides to produce some type of ocular scar lesion in humans seems not to be of 
epidemiologic importance, as we have not detected ocular scar lesions in patients 
seronegative to T. gondii and positive to A. lumbricoides in our surveys.  
The recent adoption of massive anti-helminthic treatments for people living in poor 
communities as a measure of public health policy has made difficult the research on 
individuals co-infected with A. lumbricoides and T. gondii in Campos dos Goytacazes as well 
as in other parts of Brazil. For this reason, we have begun to work with an experimental 
model of co-infection with T. gondii and Heligmosomoides polygyrus, which has been shown as 
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valid model for studying parasites that evoke polar Th-1 and Th-2 in mice. H. polygyrus is a 
gastrointestinal worm, a natural parasite to mice, which evokes a polarized Th2 response in 
the host and blocks the type 1 immune response [39, 40]. It has been shown that a previous 
infection with the helminth can inhibit the development of CD8 T-cell immune response 
against T. gondii, thus compromising long-term protection against a protozoan parasite [41], 
which illustrates the adequacy of the model for studying the interaction between helminthic 
and T. gondii infections. 
5. Immunogenetic studies: Candidate genes on ocular toxoplasmosis 
Studies on genetic association in human toxoplasmosis in the past have provided evidence 
of associations between human leukocyte antigen (HLA) genes with the susceptibility to 
toxoplasmic encephalitis in AIDS patients (42)  and with the outcome of congenital 
toxoplasmosis [43]. However, no causal relationships have been proven so far. We have 
conducted genetic association studies of candidate genes which potentially influence the 
profile of the inflammatory response against T. gondii (17, 18, 37) in patients with ocular 
toxoplasmosis by means of single  nucleotide polymorphisms  (SNPs) analysis. Significant 
associations between genetic polymorphisms and ocular disease in family-based studies have 
been found for Toll-like receptor-9, (TLR-9) [17], P2X7 purinoceptor 7 (P2RX7) [18] and 
nucleotide-binding oligomerization domain-containing protein 2 (NOD2) [37] genes. These 
studies are currently being expanded to be replicated into population     n-based 
investigational projects. All of these genes are related to innate immunity and have been 
described in processes of inflammasome assembly, which plays an important role in 
processing IL-1 beta and other IL-1 beta cytokine family member (IL-18, IL-33) precursors in 
active cytokines, promoting a pro-inflammatory response [44].The SNPs rs352140 at TLR-9 and 
rs3135499 at NOD2 were statistically significantly associated with the manifestation of ocular 
toxoplasmosis [17, 37] while the absence of the SNP rs1718119 at P2RX7 was strongly 
associated with protection to ocular disease manifestation [18] as we shall see in detail.    
The product of the P2RX7 belongs to the family of purinoceptors for ATP, 595 amino acids 
in length and highly polymorphic. The relative amount of P2X7 function varies between 
human individuals because of the numerous single nucleotide polymorphisms; 
combinations of these polymorphisms give rise to various haplotypes that can modify P2X7 
function and result in either loss or gain of function [45]. Splice isoforms that can alter 
receptor expression and function and modify the signaling properties downstream of 
receptor have also been described [45]. 
The receptor functions as a ligand-gated ion channel and is responsible for ATP-dependent 
lysis of macrophages by means of the formation of membrane pores that are permeable to 
large molecules. The receptor P2X7 functions as a pro-inflammatory receptor in cells of the 
monocyte/macrophage lineage and is activated by extracellular ATP released from a variety 
of cellular sources including platelets and damaged cells [46] Its expression is up-regulated 
by IFN-γ and can lead directly to the killing of intracellular pathogens including T. gondii 
[46, 47]. P2X7 stimulates inflammasome activation and secretion of IL-1β [48]. 
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Polymorphisms at the P2RX7 have been investigated in a cooperative immunogenetic study 
involving patients from United State and Campos dos Goytacazes in Brazil. The studies 
comprised 149 child in 149 child/parent trios from North America and 60 families with 68 
affected with postnatal ocular toxoplasmosis offspring in Brazil [18]. For the United states 
casuistic, an association between the derived C(+)G(−) allele and a second synonymous 
variant rs1621388 in linkage disequilibrium with it; and clinical signs of disease per se. were 
observed . Analysis of clinical sub-groups showed associations with retinal disease and 
brain calcifications (OR=3.0 to 4.25; 0.004<P<0.009). The association with toxoplasmic 
retinochoroiditis was replicated in a family-based study from Campos dos Goytacazes (60 
families; 68 affected offspring), where the ancestral T(+) allele (f= 0.296) at SNP rs1718119 
which contains the Ala-348 to Thr polymorphism was strongly protective (OR= 0.27; 95% CI: 
0.09–0.80) [18]. This last association at SNP rs1718119 was recently replicated in a case-
control study with 361 non-related individuals. The study confirmed the protective 
association of the T(+) allele (f= 0.296) (OR =0,3; 95% CI: 0,15-0,59 chi-square value = 13,53 p 
corrected for multiple comparisons = 0.0132) for patients with type B scar lesions [49]  
The SNPs at the P2RX7 may be associated with a gain or loss of function of the receptor. 
Data from Stokes and colleagues [50] showed the gain of function for P2X7 haplotypes 
carrying rs1718119 SNP, which matches our recent case-control data that confirmed a strong 
protection due to the ancestral allele T(+) for the P2RX7 associated with the development of 
ocular disease. Therefore, it is reasonable to speculate that the ancestral allele (that do not 
carry the rs1718119 SNP and do not contain the Ala-348 to Thr polymorphism) would help 
to protect against an exacerbated immune response as a consequence of the gain of function 
conferred by the rs1718119 SNP, which would lead to an immune response with high levels 
of pro-inflammatory cytokines, such as IL-1 β and IFN-, and could contribute to retinal 
tissue damage. Our data provides evidence that the Th-1 specific immune response is 
centered in the IFN- secretion by PBMC of patients with the different types of 
retinal/retinochoroidal scar lesions, which also reinforces the supposition that an 
exacerbated immune response in an environment with prolonged inflammatory mediators 
can contribute to retinal/retinochoroidal damage. 
Albuquerque and colleagues described an association between the IFN- +874T/A gene 
polymorphism with toxoplasmic retinochoroiditis susceptibility [51]. This study is related to 
the Santa Rita (Barra Mansa) casuistic, as described previously in this chapter. The authors 
found that AA homozygous individuals showed a 1.62-fold higher risk than other geno-
types (AT and TT) for developing toxoplasmic retinochoroiditis [51]. Regarding the IFN- 
+874T/A gene polymorphism, it was demonstrated that the polymorphism is linked to high 
and low producer phenotypes [27, 28] and the genotype AA is associated with the 
phenotype for low IFN- capacity of production in contrast to the AT or TT genotypes that 
are linked with a phenotype for a middle and high IFN- capacity of production respectively 
[29]. The T to A polymorphism coincides with a putative NF-kappa B binding site that may 
have functional consequences for the transcription of the human IFN- gene [27]. In the 
Santa Rita study, the IFN- production by PMBC of the patients was not reported. However, 
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considering that this cytokine is a very important to parasite control replication, the patients 
presenting the AA genotype for the IFN- +874 T/A polymorphism likely have a similar 
profile of specific cellular immune response with that observed for the group that presented 
lesions of types B and BC, as shown in Figure 3, and multiple type scar lesions, as shown in 
Figure 4. Namely, they would tend to produce moderate to low levels of IFN- and IL-13 
and low levels of CXCL 10, which most likely causes an immune response that is not 
sufficient to efficiently prevent/control parasite proliferation; as a consequence, 
retinal/retinochoroidal tissues damage occurs. It is important to note that to determine the 
frequency of the genotype AA among individuals grouped by the type of scar lesions, in 
association with phenotypic parameters of the immune response, like cytokines and 
chemokines, would be of value to improve our understanding of the possible pathological 
mechanisms that occur in the different types of scar lesions in ocular toxoplasmosis.   
Other reports in the literature have described genetic association studies of cytokines with 
toxoplasmic ocular diseases in Brazil. However, they describe small casuistic related to 
patients from ophthalmologic reference centers and do not find significant associations [52-
54], although one suggests the association of polymorphism at IL-1 alfa gene and the 
recurrence of ocular toxoplasmosis [54].  
6. Conclusion  
We have presented data related to a decade of research on a hyperendemic area to T. gondii 
infection, considering aspects linked to the clinical presentation of ocular disease in a 
population exposed to high risk of waterborne toxoplasmosis, the profile of in vitro specific 
immune response in the function of the disease’s clinical presentation, and genetic 
association studies with candidate genes in ocular toxoplasmosis.  
It is important to consider the conclusions and advances that can be derived based on the 
study of PBMC from patients who exhibit different clinical presentations of ocular 
toxoplasmosis, stimulated in vitro with parasite antigens. One can argue that the study of the 
specific responses of PBMC in vitro does not reflect the eye’s immune-privileged environment, 
for instance. However, the study of PBMC represents is a non-invasive approach that is 
adequate for population-based studies such that in the genomic medicine era, it will improve 
our understanding of relevant gene response, i.e., their activation and regulation in 
inflammatory process within the eye. The associations between phenotype and genotype data 
from cohorts accelerate our understanding of the molecular mechanisms involved in the 
disease’s pathology. Our data on P2X7 genotyping genes together with the PBMC immune 
profile illustrate this aspect. Namely, our initial hypothesis on an exacerbation of the 
inflammatory response with high levels of pro-inflammatory cytokines, especially IFN- 
secretion, concomitant with relatively low levels of anti-inflammatory cytokines like IL-13 
secretion in response to parasite antigens, which was identified by in vitro PBMC stimulation 
experiments and could contribute to the development of ocular disease, is reinforced by the 
findings on P2RX7 genotypingat the SNP rs1718119. This data showed that the ancestral allele 
is highly protective for the development of ocular disease. The SNP rs1718119 has been 
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demonstrated to confer a gain of function to the receptor P2X7, imbuing it with a more 
vigorous pro-inflammatory response. Therefore, the presence of the ancestral allele would 
protect the eye tissues from harmful exacerbations of immune responses, which corroborates 
our previous interpretations from PBMC experiments, as described above. Furthermore, the 
similarity of immunologic parameters between the mouse model and human infection, such as 
that observed for IFN- and CXCL10, motivates the development of innovative protocols using 
PBMC to access the gene response at the patient level. This approach is both feasible and 
suitable. For instance, in a given patient, it is possible to study PBMC to access the expression 
of the P2X7 protein, the product of the same P2RX7 that is expressed in retinal epithelial cells. 
Concerning the relevance of this approach, it is worth mentioning that primary cultures of 
human retinal epithelial cells that express P2X7 protein [55] are responsive to IFN-γ 
stimulation leading to T. gondii elimination in a pathway independent of nitric oxide (NO) [36]. 
The interpretations of our data on PBMC in vitro stimulation with T. gondii antigens together 
with the candidate genes genotyping relevant to the innate immune response, targeting the 
parasite, contribute to a better understanding of the immunological pathogenesis of 
infectious diseases that has been recently achieved. However, many issues remain to be 
addressed before the clinical exploitation of these findings can be realized. The function of 
these elements and their interplay with one another and with other components in the 
immune system are complex, and it is crucial to determine the balance between their 
beneficial and pathological roles in ocular toxoplasmosis. 
Finally, the immune responses of patients from population-based studies who exhibit diverse 
scar lesions that are likely caused by T. gondii infection illustrate the multifactorial nature of 
ocular toxoplasmosis. Beyond host genetics and interactions with other pathogens that we have 
mentioned in this chapter, there are many other factors, such as environmental questions, the 
age at which individuals are infected, the parasitic load in the host, and the parasite genetic 
background that are equally important for disease manifestation. Therefore, all of these aspects, 
in addition to those not mentioned here or unknown, that characterize the multifactorial nature 
of ocular toxoplasmosis cannot be considered separately, and their interaction in and with the 
host will be expressed by one single feature that represents the profile of the immune response 
mounted by the host. The immune response will be subject to influences by every factor and 
will ultimately impact the different clinical presentation of ocular toxoplasmosis.  
Author details 
Lílian M.G. Bahia-Oliveira*, Alba L.P. Rangel, Marcela S.B. Boechat,   
Bianca M. Mangiavacchi**, Livia M. Martins**, Francielle B. Ferraz**,  
Maycon B. Almeida and Flavia P. Vieira 
Laboratório de Biologia do Reconhecer (LBR) Centro de Biociências e Biotecnologia (CBB) 
Universidade Estadual do Norte Fluminense Darcy Ribeiro (UENF), Campos dos Goytacazes,  
RJ, Brazil 
                                                                 
* Corresponding Author 
** Equal Contribution 
 
Toxoplasmosis – Recent Advances 168 
Elisa M. Waked Peixoto and Ricardo G. Peixe 
Laboratório de Biologia do Reconhecer (LBR) Centro de Biociências e Biotecnologia (CBB) 
Universidade Estadual do Norte Fluminense Darcy Ribeiro (UENF),Campos dos Goytacazes,  
RJ, Brazil 
Faculdade de Medicina de Campos, Campos dos Goytacazes, RJ, Brazil 
Acknowledgement 
The following grants supported this work: FAPERJ E-26/112.045/2008; E-26/110.869/2009; 
E26/111.131/2010; E-26/111.305/2010  
We thank Jennifer Blackwell, Ricardo Gazzinelli and Miriam Dutra for their partnership on 
genetic studies and JP Dubey for research support. We are thank to Fernando Orefice and 
Wesley Campos for their participation on the fundoscopic examinations of patients in 
Campos dos Goytacazes and Liliani Souza Elias, Fernando Cesar Lopes and Flavia Rangel 
for their technical support. We thank Dr. Daíse Malheiros Meira, for her brilliant and 
original suggestion to propose a classification of the retinal/retinochoroidal scars in terms of 
the degree of retinal tissues destruction. 
7. References 
[1] Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, Alves CC, Orefice F, Addiss DG. Highly 
endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect 
Dis. 2003;9(1):55-62. Epub 2003/01/21. 
[2] Gilbert RE, Stanford MR. Is ocular toxoplasmosis caused by prenatal or postnatal 
infection? The British journal of ophthalmology. 2000;84(2):224-6. Epub 2000/02/03. 
[3] Holland GN, O´Connor GR, Belfort Junior R, al. E. Toxoplasmosis. St. Louis: Mosby; 
1996. 
[4] Glasner PD, Silveira C, Kruszon-Moran D, Martins MC, Burnier Junior M, Silveira S, et 
al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. American 
journal of ophthalmology. 1992;114(2):136-44. Epub 1992/08/15. 
[5] de Abreu MT, Boni D, Belfort Junior R, Passos A, Garcia AR, Muccioli C, et al. 
Toxoplasmose ocular em Venda Nova do Imigrante, ES, Brasil. Arquivos Brasileiros de 
Oftalmologia. 1998;61:540-5. 
[6] Garcia JL, Navarro IT, Ogawa L, de Oliveira RC, Kobilka E. [Seroprevalence, 
epidemiology and ocular evaluation of human toxoplasmosis in the rural zone 
Jauguapita (Parana) Brazil]. Revista panamericana de salud publica = Pan American 
journal of public health. 1999;6(3):157-63. Epub 1999/10/12. Soroprevalencia, 
epidemiologia e avaliacao ocular da toxoplasmose humana na zona rural de Jaguapita 
(Parana), Brasil. 
[7] Bahia Oliveira LM, Wilken de Abreu AM, Azevedo-Silva J, Orefice F. Toxoplamosis in 
southeastern Brazil: an alarming situation of highly endemic acquired and congennital 
Immunological and Immunogenetic Parameters on the Diversity of Ocular Toxoplasmosis: Evidence  
to Support Morphological Criteria to Classify Retinal/Retinochoroidal Scar Lesions in Epidemiologic Surveys. 169 
infection.  Recent trends in research on congennital toxoplasmosis: International Journal 
for Parasitology; 2001. p. 133-6. 
[8] Portela RW, Bethony J, Costa MI, Gazzinelli A, Vitor RW, Hermeto FM, et al. A 
multihousehold study reveals a positive correlation between age, severity of ocular 
toxoplasmosis, and levels of glycoinositolphospholipid-specific immunoglobulin A. J 
Infect Dis. 2004;190(1):175-83. Epub 2004/06/15. 
[9] Aleixo AL, Benchimol EI, Neves Ede S, Silva CS, Coura LC, Amendoeira MR. 
[Frequency of lesions suggestive of ocular toxoplasmosis among a rural population in 
the State of Rio de Janeiro]. Revista da Sociedade Brasileira de Medicina Tropical. 
2009;42(2):165-9. Epub 2009/05/19. Frequencia de lesoes sugestivas de toxoplasmose 
ocular em uma populacao rural do Estado do Rio de Janeiro. 
[10] Orefice F, Bahia Oliveira LM. Toxoplasmose. In: Médica C, editor. Uveíte Clínica e 
cirúrgica. 2 ed. Rio de Janeiro2005. 
[11] Bahia-Oliveira LM, Silva JA, Peixoto-Rangel AL, Boechat MS, Oliveira AM, Massara CL, 
et al. Host immune response to Toxoplasma gondii and Ascaris lumbricoides in a 
highly endemic area: evidence of parasite co-immunomodulation properties influencing 
the outcome of both infections. Mem Inst Oswaldo Cruz. 2009;104(2):273-80. Epub 
2009/05/12. 
[12] Smith JR, Cunningham ET, Jr. Atypical presentations of ocular toxoplasmosis. Current 
opinion in ophthalmology. 2002;13(6):387-92. Epub 2002/11/21. 
[13] Silveira C, Belfort R, Jr., Muccioli C, Abreu MT, Martins MC, Victora C, et al. A follow-
up study of Toxoplasma gondii infection in southern Brazil. American journal of 
ophthalmology. 2001;131(3):351-4. Epub 2001/03/10. 
[14] Sibley LD, Boothroyd JC. Virulent strains of Toxoplasma gondii comprise a single 
clonal lineage. Nature. 1992;359(6390):82-5. Epub 1992/09/03. 
[15] Khan A, Taylor S, Su C, Mackey AJ, Boyle J, Cole R, et al. Composite genome map and 
recombination parameters derived from three archetypal lineages of Toxoplasma 
gondii. Nucleic acids research. 2005;33(9):2980-92. Epub 2005/05/25. 
[16] Peixoto-Rangel AL. Investigação de Fatores Imunogenéticos Associados à Manifestação 
de Retinocoroidites Toxoplásmicas em Área Altamente Endêmica para Toxoplasmose. 
[Tese de Doutorado] Campos dos Goytacazes: Universidade Estadual do Norte 
Fluminense Darcy Ribeiro; 2008. 
[17] Peixoto-Rangel AL, Miller EN, Castellucci L, Jamieson SE, Peixe RG, Elias LD, et al. 
Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-
like receptor 9 (TLR9). Mem I Oswaldo Cruz. 2009;104(8):1187-90. 
[18] Jamieson SE, Peixoto-Rangel AL, Hargrave AC, de Roubaix LA, Mui EJ, Boulter NR, et 
al. Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and 
toxoplasmosis. Genes Immun. 2010;11(5):374-83. 
[19] Kee C, Koo H, Ji Y, Kim S. Effect of optic disc size or age on evaluation of optic disc 
variables. The British journal of ophthalmology. 1997;81(12):1046-9. Epub 1998/03/14. 
[20] Holland GN. Ocular toxoplasmosis: the influence of patient age. Mem Inst Oswaldo 
Cruz. 2009;104(2):351-7. Epub 2009/05/12. 
 
Toxoplasmosis – Recent Advances 170 
[21] Azevedo-Silva J. Avaliação da Resposta Imunológica contra Antígenos de Toxoplasma 
gondii e Ascaris lumbricoides em Pacientes Residentes em Áreas Co-endêmicas para 
Ambos os Parasitas em Campos dos Goytacazes/RJ. [Dissertação de Mestrado] Campos 
dos Goytacazes: Universidade Estadual do Norte Fluminense Darcy Ribeiro; 2001. 
[22] Boechat MSB. Perfil de Quimiocinas em Indivíduos Portadores de Lesão Ocular 
Decorrente da Infecção pelo Toxoplasma gondii. [Dissertação de Mestrado] Campos 
dos Goytacazes: Universidade Estadual do Norte Fluminense Darcy Ribeiro; 2008. 
[23] Garweg JG, Candolfi E. Immunopathology in ocular toxoplasmosis: facts and clues. 
Mem Inst Oswaldo Cruz. 2009;104(2):211-20. Epub 2009/05/12. 
[24] Lahmar I, Abou-Bacar A, Abdelrahman T, Guinard M, Babba H, Ben Yahia S, et al. 
Cytokine profiles in toxoplasmic and viral uveitis. J Infect Dis. 2009;199(8):1239-49. 
Epub 2009/03/24. 
[25] Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-gamma: the major 
mediator of resistance against Toxoplasma gondii. Science. 1988;240(4851):516-8. Epub 
1988/04/22. 
[26] Norose K, Kikumura A, Luster AD, Hunter CA, Harris TH. CXCL10 is required to 
maintain T-cell populations and to control parasite replication during chronic ocular 
toxoplasmosis. Investigative ophthalmology & visual science. 2011;52(1):389-98. Epub 
2010/09/03. 
[27] Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide 
polymorphism in the first intron of the human IFN-gamma gene: absolute correlation 
with a polymorphic CA microsatellite marker of high IFN-gamma production. Human 
immunology. 2000;61(9):863-6. Epub 2000/10/29. 
[28] Gomes JAS, Bahia-Oliveira LMG, Rocha MOC, Martins-Filho OA, Gazzinelli G, Correa-
Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' 
disease is due to a thl-specific immune response. Infect Immun. 2003;71(3):1185-93. 
[29] Ben Selma W, Harizi H, Bougmiza I, Hannachi N, Ben Kahla I, Zaieni R, et al. Interferon 
gamma +874T/A polymorphism is associated with susceptibility to active pulmonary 
tuberculosis development in Tunisian patients. DNA and cell biology. 2011;30(6):379-87. 
Epub 2011/02/22. 
[30] Lemaitre C, Thillaye-Goldenberg B, Naud MC, de Kozak Y. The effects of intraocular 
injection of interleukin-13 on endotoxin-induced uveitis in rats. Investigative 
ophthalmology & visual science. 2001;42(9):2022-30. Epub 2001/08/02. 
[31] Roberge FG, de Smet MD, Benichou J, Kriete MF, Raber J, Hakimi J. Treatment of 
uveitis with recombinant human interleukin-13. The British journal of ophthalmology. 
1998;82(10):1195-8. Epub 1999/01/30. 
[32] Pfefferkorn ER. Interferon gamma blocks the growth of Toxoplasma gondii in human 
fibroblasts by inducing the host cells to degrade tryptophan. Proceedings of the 
National Academy of Sciences of the United States of America. 1984;81(3):908-12. Epub 
1984/02/01. 
[33] Gazzinelli RT, Eltoum I, Wynn TA, Sher A. Acute cerebral toxoplasmosis is induced by 
in vivo neutralization of TNF-alpha and correlates with the down-regulated expression 
Immunological and Immunogenetic Parameters on the Diversity of Ocular Toxoplasmosis: Evidence  
to Support Morphological Criteria to Classify Retinal/Retinochoroidal Scar Lesions in Epidemiologic Surveys. 171 
of inducible nitric oxide synthase and other markers of macrophage activation. Journal 
of immunology. 1993;151(7):3672-81. Epub 1993/10/01. 
[34] Halonen SK, Weiss LM. Investigation into the mechanism of gamma interferon-
mediated inhibition of Toxoplasma gondii in murine astrocytes. Infect Immun. 
2000;68(6):3426-30. Epub 2000/05/19. 
[35] Norose K, Mun HS, Aosai F, Chen M, Piao LX, Kobayashi M, et al. IFN-gamma-
regulated Toxoplasma gondii distribution and load in the murine eye. Investigative 
ophthalmology & visual science. 2003;44(10):4375-81. Epub 2003/09/26. 
[36] Nagineni CN, Pardhasaradhi K, Martins MC, Detrick B, Hooks JJ. Mechanisms of 
interferon-induced inhibition of Toxoplasma gondii replication in human retinal 
pigment epithelial cells. Infect Immun. 1996;64(10):4188-96. Epub 1996/10/01. 
[37] Dutra MS, Béla SR, Peixoto-Rangel AL, Fakiola M, Gazzinelli A, Quites HF, et al. 
Association of a NOD2 gene polymorphism and responsiveness of Th17 lymphocytes 
with ocular toxoplasmosis. The Journal of Infectious Diseases (accepted for publication).  
[38] de Visser L. Infectious uveitis: New developments in etiology and pathogenesis. [PhD 
Thesis] Netherlands: Utrecht University 2009. 
[39] Svetic A, Madden KB, Zhou XD, Lu P, Katona IM, Finkelman FD, et al. A primary 
intestinal helminthic infection rapidly induces a gut-associated elevation of Th2-
associated cytokines and IL-3. Journal of immunology. 1993;150(8 Pt 1):3434-41. Epub 
1993/04/15. 
[40] Setiawan T, Metwali A, Blum AM, Ince MN, Urban JF, Jr., Elliott DE, et al. 
Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the 
murine normal distal intestine. Infect Immun. 2007;75(9):4655-63. Epub 2007/07/04. 
[41] Khan IA, Hakak R, Eberle K, Sayles P, Weiss LM, Urban JF, Jr. Coinfection with 
Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against 
Toxoplasma gondii. Infect Immun. 2008;76(3):1305-13. Epub 2008/01/16. 
[42] Suzuki Y, Wong SY, Grumet FC, Fessel J, Montoya JG, Zolopa AR, et al. Evidence for 
genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J Infect 
Dis. 1996;173(1):265-8. Epub 1996/01/01. 
[43] Mack DG, Johnson JJ, Roberts F, Roberts CW, Estes RG, David C, et al. HLA-class II 
genes modify outcome of Toxoplasma gondii infection. International journal for 
parasitology. 1999;29(9):1351-8. Epub 1999/12/01. 
[44] Stutz A, Golenbock DT, Latz E. Inflammasomes: too big to miss. The Journal of clinical 
investigation. 2009;119(12):3502-11. Epub 2009/12/04. 
[45] Sluyter R, Stokes L. Significance of P2X7 receptor variants to human health and disease. 
Recent patents on DNA & gene sequences. 2011;5(1):41-54. Epub 2011/02/10. 
[46] Correa G, Marques da Silva C, de Abreu Moreira-Souza AC, Vommaro RC, Coutinho-
Silva R. Activation of the P2X(7) receptor triggers the elimination of Toxoplasma gondii 
tachyzoites from infected macrophages. Microbes and infection / Institut Pasteur. 
2010;12(6):497-504. Epub 2010/03/20. 
[47] Lees MP, Fuller SJ, McLeod R, Boulter NR, Miller CM, Zakrzewski AM, et al. P2X7 
receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human 
 
Toxoplasmosis – Recent Advances 172 
and murine macrophages. Journal of immunology. 2010;184(12):7040-6. Epub 
2010/05/22. 
[48] Qu Y, Franchi L, Nunez G, Dubyak GR. Nonclassical IL-1 beta secretion stimulated by 
P2X7 receptors is dependent on inflammasome activation and correlated with exosome 
release in murine macrophages. Journal of immunology. 2007;179(3):1913-25. Epub 
2007/07/21. 
[49] Ferraz FB. Estudo caso-controle e frequências alélicas de SNPs de P2RX7 em coorte de 
indivíduos com lesão ocular toxoplásmica no norte do estado do Rio de Janeiro. 
[Dissertação de mestrado] Campos dos Goytacazes: Universidade Estadual do Norte 
Fluminense Darcy Ribeiro; 2012. 
[50] Stokes L, Fuller SJ, Sluyter R, Skarratt KK, Gu BJ, Wiley JS. Two haplotypes of the 
P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function 
effect and enhanced interleukin-1beta secretion. FASEB journal : official publication of 
the Federation of American Societies for Experimental Biology. 2010;24(8):2916-27. Epub 
2010/04/03. 
[51] Albuquerque MC, Aleixo AL, Benchimol EI, Leandro AC, das Neves LB, Vicente RT, et 
al. The IFN-gamma +874T/A gene polymorphism is associated with retinochoroiditis 
toxoplasmosis susceptibility. Mem Inst Oswaldo Cruz. 2009;104(3):451-5. Epub 
2009/06/24. 
[52] Cordeiro CA, Moreira PR, Costa GC, Dutra WO, Campos WR, Orefice F, et al. TNF-
alpha gene polymorphism (-308G/A) and toxoplasmic retinochoroiditis. The British 
journal of ophthalmology. 2008;92(7):986-8. Epub 2008/06/26. 
[53] Cordeiro CA, Moreira PR, Costa GC, Dutra WO, Campos WR, Orefice F, et al. 
Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Molecular vision. 
2008;14:1845-9. Epub 2008/10/23. 
[54] Cordeiro CA, Moreira PR, Andrade MS, Dutra WO, Campos WR, Orefice F, et al. 
Interleukin-10 gene polymorphism (-1082G/A) is associated with toxoplasmic 
retinochoroiditis. Investigative ophthalmology & visual science. 2008;49(5):1979-82. 
Epub 2008/04/26. 
[55] Yang D, Elner SG, Clark AJ, Hughes BA, Petty HR, Elner VM. Activation of P2X 
receptors induces apoptosis in human retinal pigment epithelium. Investigative 
ophthalmology & visual science. 2011;52(3):1522-30. Epub 2010/11/13. 
[56] Melamed J. Contributions to the history of ocular toxoplasmosis in Southern Brazil. 
Memórias do Instituto Oswaldo Cruz. 2009;104(2):358-63. 
[57] Dubey J, Gennari S, Lago E, Su C, Jones J. Toxoplasmosis in humans and animals in 
Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012. 
doi:10.1017/S0031182012000765 
